Chromosomal rearrangement is the key to progress against aggressive infant leukemia
St. Jude Children’s Research Hospital—Washington University Pediatric Cancer Genome Project study highlights need for targeted therapies against a rare infant leukemia with a poor prognosis. (James R. Downing, MD)
Source: St. Jude Children's Research Hospital - Category: Pediatrics Source Type: news
More News: Cancer | Cancer & Oncology | Children | Hospitals | Leukemia | Pediatrics | Study | Washington University